AzTrials
AzTrials

Spinal Cord InjuriesNCT03998527

Non-Invasive Spinal Cord Stimulation After Injury

A study testing Transcutaneous Electrical Spinal Cord Stimulation (TcESCS) in people with Spinal Cord Injuries, run by University of Louisville at 1 site in United States.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

The goal of this study is to assess the function of the lungs and the muscles are used to breathe after individuals receive respiratory training, spinal cord stimulation, a combination of respiratory training and stimulation, a combination of arm training and stimulation, or a combination of trunk training and… Read more about this study

Who is it for?
Ages 18 to 99 yearsHealthy volunteers can take part
Conditions the study is for
Spinal Cord Injuries
What is being tested?
Transcutaneous Electrical Spinal Cord Stimulation (TcESCS)
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
36 participants
Where
1 siteUnited States
Study dates
17 May 2018to 31 Dec 2029
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 99 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • At least 18 years of age at the time of enrollment;
  • Stable medical condition;
  • Non-progressive SCI T5 or above;
  • Sustained SCI at least 12 months prior to enrollment;
  • At least a 15% deficit in pulmonary function outcomes (FVC or FEV1) as was detected by screening spirometry
  • At least 21 years of age at the time of enrollment.
  • FVC and FEV1 values 80% of predicted or above indicating healthy pulmonary function by screening spirometry.

Who cannot join

  • Untreated musculoskeletal dysfunction;
  • Unhealed fracture;
  • Untreated contracture or pressure sore;
  • Ventilator dependence;
  • Untreated depression, psychiatric disorder, or ongoing drug abuse;
  • Major pulmonary or cardiovascular disease;
Show all 13Show fewer
  • Major esophageal or gastrointestinal disease;
  • Endocrine disorder, malignancy, marked obesity, deep vein thrombosis, or HIV/AIDS related illness;
  • Secondary causes of orthostatic hypotension (anemia, hypervolemia, endocrine, or neurological);
  • Pregnancy by self-report.
  • All Non-Disabled research participants, irrespective of gender, will be selected based on the following:
  • History of respiratory disease by self-report,
  • History of cardiovascular disease by self-report.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Frazier Rehabilitation and Neuroscience Institute

    Louisville, Kentucky, 40202

Other trials in United States

About this study

Official title: Non-Invasive Spinal Cord Stimulation and Respiratory Plasticity

The goal of this study is to assess the function of the lungs and the muscles are used to breathe after individuals receive respiratory training, spinal cord stimulation, a combination of respiratory training and stimulation, a combination of arm training and stimulation, or a combination of trunk training and stimulation. The respiratory, arm, and trunk training combined with the spinal stimulation interventions are being used to activate the spinal cord below the level of injury. Investigators will be looking for changes in the function of the lungs and trunk muscles before, during, and after these task-specific and non-task-specific interventions for breathing to determine which one has the greatest effect. The results of this study may aid in the development of treatments to help individuals with spinal cord injuries that have impaired lung, arm, and trunk function.

Read the detailed description

Study Aim 1. This study is aimed to evaluate the effects of non-invasive transcutaneous electrical spinal-cord stimulation (TcESCS) applied below the neurological level of Spinal Cord Injury (SCI) on respiratory, upper extremity, and trunk functional and motor control properties and identify their underlying physiological mechanisms. Evaluation of the mechanisms of respiratory and motor control modulations evoked by the TcESCS will have important implications for the development of specific therapeutic strategies to fight complications of SCI. The objective of Aim 1 is to investigate whether TcESCS can significantly increase activation of motor networks. This work will be done by electrophysiological characterization of respiratory and other motor responses as assessed at rest and in response to the respiratory and other challenges in SCI individuals. Changes in functional measures will be assessed when the TcESCS device is turned "off" and "on". To evaluate "dose-dependent" effects, changes in surface electromyographic (sEMG) magnitude and muscle co-activation will be assessed when stimulation parameters and location are changed during respiratory efforts and motor tasks. The extent to which the stimulation is associated with the largest change in respiratory and sEMG parameters will be implemented as a strategy to be used during stimulation in combination with Respiratory Training (RT), Arm Training (AT), and Trunk Training (TT). To attain the objective of this aim, we will test the working hypothesis that TcESCS excites specific motor networks leading to amplified motor responses. We will test this hypothesis by applying TcESCS during our original approach of the Respiratory Motor Control Assessment (RMCA) and other sEMG-based assessments with kinematics to characterize respiratory, arm, and trunk motor function. During these assessments, beat-to-beat Blood Pressure/ Heart Rate (BP/HR), and respiratory rate will be recorded to evaluate respiratory-cardiovascular responses. The rationale for this aim is that successful completion of the proposed research will contribute fundamental elements to our basic knowledge, without which the therapeutic value of TcESCS cannot be understood. The acquisition of such knowledge is critical to the development of specific rehabilitative strategies. When the proposed studies for Aim 1 have been completed, we expect that motor and inter-related characteristics affected by TcESCS in patients with SCI will be established. Such findings would be important because it will allow us, for the first time, to evaluate the ability of non-invasive spinal cord stimulation to enhance the decreased state of spinal network activity thus demonstrating the potential for rehabilitation.

Study Aim 2. The goal is to evaluate the effectiveness and therapeutic mechanisms of the TcESCS combined with task-specific (Respiratory Training) and non-task-specific (Arm Training and Trunk Training) interventions for breathing. Identification of the physiological effects of potential rehabilitative approaches will have important implications for the development of specific therapeutic strategies. The objective of Aim 2 is to investigate the therapeutic effects of RT regimen in combination with TcESCS. This work will be done by using methods outlined in Aim 1 and additional clinical measures all assessed before training, and repeatedly during follow-up period. Working hypothesis that compare to RT alone and TcESCS alone, RT assisted by TcESCS leads to enhanced use-dependent plasticity of respiratory motor networks, leading the functional recovery will be tested by using the approach of detecting changes in respiratory and other motor control outcome measures in response to stimulation and training. The rationale for this aim is that successful completion of the proposed research will advance the field by providing new avenues for the application of activity-based therapy accompanied by the spinal cord stimulation. When the proposed studies for Aim 2 have been completed, it is expected that the rehabilitative capacity of RT with TcESCS will be determined. Such results are important, because, for the first time, identified therapeutic mechanisms of TcESCS will provide evidence that this intervention can enhance the effects of activity-based therapy in participants with SCI.

Being tested
Transcutaneous Electrical Spinal Cord Stimulation (TcESCS)
Keywords
Respiration, Motor control
Medical subject headings
Spinal Cord Injuries, Respiratory Aspiration

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Transcutaneous Electrical Spinal Cord Stimulation (TcESCS)Device

    Also called Non-invasive spinal cord stimulation

    TcESCS is a non-invasive DC battery powered device. Investigators and/or research team members will continually assess the appropriate stimulation parameters including configurations, current, voltage and frequency delivered by up to five active electrodes applied on skin of the back from cervical to lumbar levels. Stimulation parameters used during experimental assessments and interventions will be closely monitored by the research team. Every research participant will be slowly acclimated to stimulation. Blood pressure, heart rate, respiratory rate, and electromyography will be closely monitored while we are determining the correct stimulation parameters in the lab. During the stimulation training sessions, we will monitor blood pressure regularly throughout the session.

Study groups in NCT03998527
Study groupRoleWhat they receive
Non-Disabled (ND) and Spinal Cord Injured (SCI) controlsExperimentalThe ND Control group (n=6) and SCI Control group (n=6) will be used to assess related values as acute effects of transcutaneous electrical spinal cord stimulation (TcESCS) itself and will not receive any training intervention. The ND group will receive baseline assessments, then up to 12 (4-Respiratory function, 4-Arm function, and 4-Trunk function) TcESCS mapping experiments, followed by repeating the assessments in the presence of TcESCS. The investigators will decide which stimulation type should be used for the post-mapping assessments.
Receives: Device: Transcutaneous Electrical Spinal Cord Stimulation (TcESCS)
Spinal Cord Injured (SCI) intervention groupsExperimentalThe respiratory training (RT) group (n=6) will receive the respiratory training intervention only); the transcutaneous electrical spinal cord stimulation (TcESCS) group (n=6) will receive transcutaneous spinal cord stimulation only; TcESCS + RT group (n=6) will receive TcESCS combined with RT; TcESCS + Arm Training (AT) group (n=6) will receive TcESCS combined with AT; and TcESCS + Trunk Training (TT) group (n=6) will receive TcESCS combined with TT.
Receives: Device: Transcutaneous Electrical Spinal Cord Stimulation (TcESCS)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Non-invasive respiratory electromyography

    Respiratory muscle activity evaluated using vector analysis outcome measure.

    Measured: Through study completion, an average of 1 year.

  2. Spirometry

    Respiratory activity evaluated using airflow outcome measure.

    Measured: Through study completion, an average of 1 year.

  3. Maximum airway pressure

    Respiratory activity evaluated using airway pressure measurement.

    Measured: Through study completion, an average of 1 year.

Secondary outcomes (7)
  1. Functional Neurophysiological Assessment (FNPA)

    The FNPA assesses the motor capacity and control of the upper and lower extremities and trunk .

    Measured: Through study completion, an average of 1 year.

  2. Multisegmental Motor Response (MMR)

    MMRs in response to non-invasive stimulation of the dorsal spinal cord assessed electromyographically

    Measured: Through study completion, an average of 1 year.

  3. Transcranial Magnetic Stimulation (TMS)

    TMS of the cortex to assess the integrity of the descending corticospinal tracts

    Measured: Through study completion, an average of 1 year.

  4. Aerobic Endurance Test (VO2Peak)

    Oxygen consumption during exercise

    Measured: Through study completion, an average of 1 year.

  5. Spinal Cord Independence Measure (SCIM)

    Questionnaire to assess Self-Care and Mobility

    Measured: Through study completion, an average of 1 year.

  6. The Craig Handicap Assessment & Reporting Technique (CHART)

    Questionnaire to measure the level of handicap in a community setting: physical independence, mobility, occupation, social integration, and economic self-sufficiency

    Measured: Through study completion, an average of 1 year.

  7. Beat-by-beat arterial blood pressure

    Non-invasive blood pressure monitoring

    Measured: During assessments.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Jun 2019
  2. Study start17 May 2018
  3. Primary completion31 Dec 2029 (estimated)
  4. Study completion31 Dec 2029 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
36 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03998527
Sponsor's protocol ID
17.1279
Status last verified
Mar 2026
First submitted
20 Jun 2019
Last updated
13 Mar 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
Yes
Individual data sharing
No

Publications

  • Gerasimenko Y, Gorodnichev R, Moshonkina T, Sayenko D, Gad P, Reggie Edgerton V. Transcutaneous electrical spinal-cord stimulation in humans. Ann Phys Rehabil Med. 2015 Sep;58(4):225-231. doi: 10.1016/j.rehab.2015.05.003. Epub 2015 Jul 20.

    PubMed 26205686

Questions about this trial

What is this clinical trial studying?

A study testing Transcutaneous Electrical Spinal Cord Stimulation (TcESCS) in people with Spinal Cord Injuries, run by University of Louisville at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 13 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 13 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Non-invasive respiratory electromyography (time frame: Through study completion, an average of 1 year.). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03998527, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Mar 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in